Éric A. Cohen
#106,938
Most Influential Person Now
Canadian biologist and virologist
Éric A. Cohen's AcademicInfluence.com Rankings
Éric A. Cohenbiology Degrees
Biology
#6775
World Rank
#9565
Historical Rank
Virology
#353
World Rank
#361
Historical Rank
Immunology
#970
World Rank
#994
Historical Rank
Molecular Biology
#2349
World Rank
#2385
Historical Rank
Download Badge
Biology
Éric A. Cohen's Degrees
- Masters Virology McGill University
- PhD Virology University of British Columbia
Why Is Éric A. Cohen Influential?
(Suggest an Edit or Addition)According to Wikipedia, Éric A. Cohen is a Canadian molecular virologist whose research is focused on human immunodeficiency virus -host interactions that govern viral replication and persistence. Education and Training Cohen graduated from Collège Jean-de-Brébeuf of Montréal in 1977 with a college diploma in Health Sciences. He received a B.Sc. in Biochemistry from McGill University in 1981 and a Ph.D. in Molecular Biology from Université de Montréal in 1987.
Éric A. Cohen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- International AIDS Society global scientific strategy: towards an HIV cure 2016 (2016) (372)
- Human immunodeficiency virus vpr product is a virion-associated regulatory protein (1990) (372)
- Identification of a protein encoded by the vpu gene of HIV-1 (1988) (305)
- Functional role of human immunodeficiency virus type 1 vpu. (1989) (282)
- Identification of HIV-1 vpr product and function. (1990) (270)
- LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated (2008) (232)
- Antagonism of Tetherin Restriction of HIV-1 Release by Vpu Involves Binding and Sequestration of the Restriction Factor in a Perinuclear Compartment (2010) (228)
- Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1 (1993) (225)
- Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. (2003) (217)
- Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. (1993) (207)
- Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation (1995) (194)
- The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles (1995) (190)
- Vpr Stimulates Viral Expression and Induces Cell Killing in Human Immunodeficiency Virus Type 1-Infected Dividing Jurkat T Cells (1998) (181)
- HIV-1 Vpr-Mediated G2 Arrest Involves the DDB1-CUL4AVPRBP E3 Ubiquitin Ligase (2007) (180)
- The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells (1994) (171)
- HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. (2010) (166)
- The Double-Stranded RNA-Binding Protein Staufen Is Incorporated in Human Immunodeficiency Virus Type 1: Evidence for a Role in Genomic RNA Encapsidation (2000) (165)
- Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2 (1986) (161)
- HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. (1998) (153)
- Human Immunodeficiency Virus Type 1 Vpr Is a Positive Regulator of Viral Transcription and Infectivity in Primary Human Macrophages (1998) (150)
- Suppression of Tetherin-Restricting Activity upon Human Immunodeficiency Virus Type 1 Particle Release Correlates with Localization of Vpu in the trans-Golgi Network (2009) (138)
- HIV-1 Vpr Causes Neuronal Apoptosis and In Vivo Neurodegeneration (2007) (131)
- Incorporation of Vpr into Human Immunodeficiency Virus Type 1 Requires a Direct Interaction with the p6 Domain of the p55 Gag Precursor* (1999) (131)
- Modulation of HIV-1-host interaction: role of the Vpu accessory protein (2010) (129)
- Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles (1994) (127)
- Activation of Transcription Factors NF-κB and NF-IL-6 by Human Immunodeficiency Virus Type 1 Protein R (Vpr) Induces Interleukin-8 Expression (2000) (119)
- Polarized Human Immunodeficiency Virus Budding in Lymphocytes Involves a Tyrosine-Based Signal and Favors Cell-to-Cell Viral Transmission (1999) (116)
- Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Functions as an Immediate-Early Protein during HIV-1 Infection (1999) (114)
- Productive Human Immunodeficiency Virus Type 1 Assembly Takes Place at the Plasma Membrane (2007) (113)
- The human immunodeficiency virus type 1 5' packaging signal structure affects translation but does not function as an internal ribosome entry site structure (1996) (109)
- HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2 (2014) (108)
- Molecular biology of the human immunodeficiency virus accessory proteins (1994) (104)
- Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum (2007) (103)
- Importin α3 Interacts with HIV-1 Integrase and Contributes to HIV-1 Nuclear Import and Replication (2010) (99)
- HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy (2016) (99)
- Hepatitis C Virus Core Protein Induces Neuroimmune Activation and Potentiates Human Immunodeficiency Virus-1 Neurotoxicity (2010) (92)
- RNA Trafficking Signals in Human Immunodeficiency Virus Type 1 (2001) (91)
- Vpu Exerts a Positive Effect on HIV-1 Infectivity by Down-modulating CD4 Receptor Molecules at the Surface of HIV-1-producing Cells* (2003) (90)
- MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase‐6 regulates astrocyte survival (2010) (88)
- Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export (1992) (84)
- The Putative Alpha Helix 2 of Human Immunodeficiency Virus Type 1 Vpr Contains a Determinant Which Is Responsible for the Nuclear Translocation of Proviral DNA in Growth-Arrested Cells (1998) (74)
- HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation (2017) (74)
- Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved. (1998) (73)
- Role of CD4 receptor down-regulation during HIV-1 infection. (2004) (71)
- Virus-Activated Interferon Regulatory Factor 7 Upregulates Expression of the Interferon-Regulated BST2 Gene Independently of Interferon Signaling (2012) (66)
- Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein. (1998) (66)
- Genome-wide RNAi Screen Reveals a New Role of a WNT/CTNNB1 Signaling Pathway as Negative Regulator of Virus-induced Innate Immune Responses (2013) (65)
- Human immunodeficiency virus type 1 Vpr‐mediated G2 cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A (2000) (64)
- Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. (1995) (64)
- HIV‐1 Vpu Antagonizes BST‐2 by Interfering Mainly with the Trafficking of Newly Synthesized BST‐2 to the Cell Surface (2011) (63)
- HIV-1 Vpr Induces the K48-Linked Polyubiquitination and Proteasomal Degradation of Target Cellular Proteins To Activate ATR and Promote G2 Arrest (2010) (61)
- Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import (2005) (60)
- Formation of Mobile Chromatin-Associated Nuclear Foci Containing HIV-1 Vpr and VPRBP Is Critical for the Induction of G2 Cell Cycle Arrest (2010) (59)
- Lentivirus Vpr and Vpx accessory proteins usurp the cullin4-DDB1 (DCAF1) E3 ubiquitin ligase. (2012) (58)
- Assessment of the Role of the Central DNA Flap in Human Immunodeficiency Virus Type 1 Replication by Using a Single-Cycle Replication System (2004) (58)
- Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration (2016) (58)
- CD4 Dimers Constitute the Functional Component Required for T Cell Activation1 (2002) (57)
- A Late Role for the Association of hnRNP A2 with the HIV-1 hnRNP A2 Response Elements in Genomic RNA, Gag, and Vpr Localization*[boxs] (2004) (57)
- Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells. (2016) (56)
- Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity. (1998) (56)
- Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. (1995) (55)
- Putative alpha-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule (1997) (55)
- Role of auxiliary proteins in retroviral morphogenesis. (1996) (55)
- HIV‐1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain (2010) (54)
- Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain (2017) (53)
- Host MicroRNAs-221 and -222 Inhibit HIV-1 Entry in Macrophages by Targeting the CD4 Viral Receptor. (2017) (50)
- Synthesis of unsymmetrical 3,4-diaryl-3-pyrrolin-2-ones utilizing pyrrole Weinreb amides. (2011) (49)
- Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence (2016) (48)
- Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein (1997) (47)
- The effect of vpu on HIV-1-induced syncytia formation. (1993) (45)
- Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice (2013) (44)
- Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag. (1995) (43)
- Dual Mechanisms of Translation Initiation of the Full-Length HIV-1 mRNA Contribute to Gag Synthesis (2013) (43)
- Deregulation of microRNAs by HIV-1 Vpr Protein Leads to the Development of Neurocognitive Disorders* (2011) (43)
- Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression. (2002) (42)
- Effects of Vpu expression on Xenopus oocyte membrane conductance. (1998) (42)
- Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of two non-identical subunits, H1 and H2. (1985) (41)
- Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells (2015) (41)
- miRNA-1236 Inhibits HIV-1 Infection of Monocytes by Repressing Translation of Cellular Factor VprBP (2014) (41)
- Cell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases. (2008) (41)
- Oral pathogens and allergic disease: results from the Third National Health and Nutrition Examination Survey. (2006) (39)
- Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress (2011) (39)
- HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect (1999) (35)
- The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway. (2013) (34)
- Major Histocompatibility Complex Class II Molecules Promote Human Immunodeficiency Virus Type 1 Assembly and Budding to Late Endosomal/Multivesicular Body Compartments (2006) (33)
- Molecular analysis of the cytoplasmic domain of CD4: overlapping but noncompetitive requirement for lck association and down-regulation by Nef. (1996) (33)
- Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity (2022) (32)
- Modulation of Allergic Airway Inflammation by the Oral Pathogen Porphyromonas gingivalis (2010) (30)
- Virion-Targeted Viral Inactivation of Human Immunodeficiency Virus Type 1 by Using Vpr Fusion Proteins (1998) (29)
- Design of a trans protease lentiviral packaging system that produces high titer virus (2007) (29)
- Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother-To-Child Transmission (2012) (29)
- LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy (2021) (28)
- Extracellular human immunodeficiency virus type 1 viral protein R causes reductions in astrocytic ATP and glutathione levels compromising the antioxidant reservoir. (2012) (28)
- Comparison of Human Immunodeficiency Virus (HIV)-Specific Infection-Enhancing and -Inhibiting Antibodies in AIDS Patients (2002) (28)
- Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase. (1987) (27)
- Genetic Selection of Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Vpr* (2002) (26)
- Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder (2015) (26)
- HIV-1 is rarely detected in blood and colon myeloid cells during viral-suppressive antiretroviral therapy. (2019) (24)
- Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence (2011) (23)
- Characterization of the cytotoxic factor(s) released from thymic dendritic cells upon human immunodeficiency virus type 1 infection. (1998) (22)
- Association between disruption of CD4 receptor dimerization and increased human immunodeficiency virus type 1 entry (2006) (22)
- The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates. (1992) (21)
- Two-step purification of His-tagged Nef protein in native condition using heparin and immobilized metal ion affinity chromatographies. (2003) (21)
- Recent advances in the understanding of HIV-1 Vpu accessory protein functions. (2004) (20)
- Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies (2016) (20)
- Differential type 1 interferon‐regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence (2013) (19)
- Neutralization of herpes simplex virus ribonucleotide reductase activity by an oligopeptide-induced antiserum directed against subunit H2 (1986) (18)
- HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4+ T Cells by NK Cells (2017) (18)
- Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex. (2007) (18)
- Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells. (2016) (18)
- Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism. (1994) (18)
- Viral protein R upregulates expression of ULBP2 on uninfected bystander cells during HIV-1 infection of primary CD4+ T lymphocytes. (2013) (17)
- Modulation of NKG2D-Mediated Cytotoxic Functions of Natural Killer Cells by Viral Protein R from HIV-1 Primary Isolates (2011) (17)
- Identification of viral polypeptides involved in pseudorabies virus ribonucleotide reductase activity (1987) (17)
- Defining the Interactions and Role of DCAF1/VPRBP in the DDB1-Cullin4A E3 Ubiquitin Ligase Complex Engaged by HIV-1 Vpr to Induce a G2 Cell Cycle Arrest (2014) (16)
- In VitroCharacterization of Purified Human Thymic Dendritic Cells Infected with Human Immunodeficiency Virus Type 1 (1996) (16)
- HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy. (2019) (16)
- The T open reading frame of human immunodeficiency virus type 1. (1990) (15)
- Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies. (1993) (15)
- Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions. (2001) (15)
- An improved method for purifying human thymic dendritic cells. (1995) (14)
- Alcian blue-treated polystyrene microtitre plates for use in an ELISA to measure antibodies against synthetic peptides. (1994) (14)
- Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiae (2004) (14)
- HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1 to disrupt centrosome homeostasis (2018) (13)
- The tyrosine-based YXXØ targeting motif of murine leukemia virus envelope glycoprotein affects pathogenesis. (2004) (13)
- Difunctional enols of N-protected amino acids as low molecular weight and novel inhibitors of HIV-1 protease. (1993) (12)
- L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection (2021) (12)
- The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research (2017) (12)
- Cell context-dependent involvement of ATR in early stages of retroviral replication. (2010) (12)
- Expression of MDM2 in Macrophages Promotes the Early Postentry Steps of HIV-1 Infection through Inhibition of p53 (2019) (12)
- Differential Control of BST2 Restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists Encoded by HIV-1 Group M and O Strains (2016) (12)
- Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A. (2000) (11)
- HIV-1 Vpu disarms natural killer cells. (2010) (11)
- Lentiviral Infections Persist in Brain despite Effective Antiretroviral Therapy and Neuroimmune Activation (2021) (11)
- Flt3L-Mediated Expansion of Plasmacytoid Dendritic Cells Suppresses HIV Infection in Humanized Mice. (2019) (11)
- In vitro characterization of purified human thymic dendritic cells infected with human immunodeficiency virus type 1. (1996) (10)
- HIV-induced neuroinflammation: impact of PAR1 and PAR2 processing by Furin (2019) (10)
- The HIV-1 Accessory Protein Vpu Downregulates Peroxisome Biogenesis (2020) (10)
- Furin cleaves SARS-CoV-2 spike-glycoprotein at S1/S2 and S2'for viral fusion/entry: indirect role for TMPRSS2 (2020) (9)
- Effect of Calcium-Modulating Cyclophilin Ligand on Human Immunodeficiency Virus Type 1 Particle Release and Cell Surface Expression of Tetherin (2009) (9)
- Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses (2019) (9)
- HIV Infection and Persistence in Pulmonary Mucosal Double Negative T Cells In Vivo (2020) (9)
- Regulation of CD4 Receptor and HIV-1 Entry by MicroRNAs-221 and -222 during Differentiation of THP-1 Cells (2017) (9)
- Erratum: Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells (Cell Metabolism (2016) 23(5) (852–866) (S1550413116301619) (10.1016/j.cmet.2016.04.010)) (2016) (9)
- Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A. (2002) (9)
- Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication (2008) (8)
- Pharmacological Inhibition of PPARy Boosts HIV Reactivation and Th17 Effector Functions, While Preventing Progeny Virion Release and de novo Infection (2020) (8)
- USP18 is a significant driver of memory CD4 T-cell reduced viability caused by type I IFN signaling during primary HIV-1 infection (2019) (8)
- CD4/CXCR4 co-expression allows productive HIV-1 infection in canine kidney MDCK cells. (2006) (7)
- Human Jurkat lymphocytes clones differ in their capacity to support productive human immunodeficiency virus type 1 multiplication. (2001) (7)
- Activation of the ILT7 receptor and plasmacytoid dendritic cell responses are governed by structurally-distinct BST2 determinants (2019) (7)
- Attacking the Supply Lines: HIV-1 Restricts Alanine Uptake to Prevent T Cell Activation. (2015) (6)
- Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107 (2020) (6)
- HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation (2016) (6)
- HIV-1 HxBc2 strain encodes a truncated vpr gene product of 78 amino acids. (1993) (6)
- RALDH Activity Induced by Bacterial/Fungal Pathogens in CD16+ Monocyte-Derived Dendritic Cells Boosts HIV Infection and Outgrowth in CD4+ T Cells (2021) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Selective effects of DNA damaging agents on HIV long terminal repeat activation and virus replication in vitro. (1996) (5)
- Mutational analysis of the HIV-1 Vpu protein. (1994) (5)
- Erratum: Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders (The Journal of Biological Chemistry (2011) 286 (34976-34985)) (2013) (5)
- Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. (2013) (4)
- Retention and expression of the left end subfragment of the herpes simplex virus type 2 BglII N DNA fragment do not correlate with tumorigenic conversion of NIH 3T3 cells. (1989) (4)
- Activities of both ribonucleotide reductase subunits, M1 and M2, decrease upon serum starvation of baby hamster kidney 21/C13 cells. (1987) (4)
- Herpes Simplex Virus Ribonucleotide Reductase Induced in Infected BHK-21 / C 13 Cells : Biochemical Evidence for the Existence of Two Non-identical Subunits , HI and H 2 (1985) (4)
- HIV-1 Vpu Promotes Phagocytosis of Infected CD4+ T Cells by Macrophages through Downregulation of CD47 (2021) (4)
- Implications of Spike-glycoprotein processing at S1/S2 by Furin, at S2’ by Furin and/or TMPRSS2 and shedding of ACE2: cell-to-cell fusion, cell entry and infectivity of SARS-CoV-2 (2020) (4)
- Conserved residues within the HIV-1 Vpu transmembrane-proximal hinge region modulate BST2 binding and antagonism (2017) (4)
- Major histocompatibility complex class‐II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane (2013) (4)
- New pandemics: HIV and AIDS, HCV and chronic hepatitis, Influenza virus and flu (2007) (3)
- Trafficking of HIV-1 RNA: Recent Progress Involving Host Cell RNABinding Proteins (2003) (3)
- Modulation of NKG2D-Mediated Cytotoxic Functions of Natural Killer Cells by Viral Protein R from HIV-1 Primary Isolates (2012) (3)
- Activation of human immunodeficiency virus 1 gene expression by the src oncoprotein. (1994) (3)
- Infection of human thymic dendritic cells with HIV-1 induces the release of a cytotoxic factor(s). (1997) (2)
- From arrest to escape: HIV-1 Vpr cuts a deal. (2014) (2)
- IL-17A reprograms intestinal epithelial cells to facilitate HIV-1 replication and outgrowth in CD4+ T cells (2021) (1)
- Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System. (2015) (1)
- Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice (2013) (1)
- Oral Pathogens and Asthma: A Potential Connection (2006) (1)
- Erratum: Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders (Journal of Biological Chemistry (2011) 286 (34976-34985) DOI:10.1074/jbc.A111.241547) (2013) (1)
- OA2-4 Enhancing HIV-1 virion tethering by BST2/tetherin sensitizes productively and latently infected T cells to ADCC mediated by broadly neutralizing anti-HIV antibodies (2016) (1)
- Generation of functional human T cell development in NOD/SCID/IL2rγnull humanized mice without using fetal tissue: Application as a model of HIV infection and persistence (2022) (1)
- RNA Trafficking Signals in Human Immunodeficiency Virus Type 1 (2001) (1)
- Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. (2013) (1)
- IL-17A imprints intestinal epithelial cells with the ability to promote HIV-1 dissemination/outgrowth in CD4 T cells (2019) (1)
- SKI-1/S1P Facilitates SARS-CoV-2 Spike Induced Cell-to-Cell Fusion via Activation of SREBP-2 and Metalloproteases, Whereas PCSK9 Enhances the Degradation of ACE2 (2023) (0)
- The HIV Restriction Factor Profile in the Brain Is Associated with the Clinical Status and Viral Quantities (2023) (0)
- Vpr usurps EDD-DYRK2-DDB1 at the centrosome 1 HIV-1 Vpr hijacks EDD-DYRK2-DDB1 to disrupt centrosome homeostasis (2018) (0)
- Modulation of Allergic Airway Inflammation by the Oral Pathogen Porphyromonas gingivalis (cid:1) (2010) (0)
- Component Required for T Cell Activation CD4 Dimers Constitute the Functional (2012) (0)
- Response To "Kinetic And Mechanistic Studies Of The Recombination Of Oh With No2: Vibrational Deactivation, Isotopic Scrambling And Product Isomer Branching Ratios" (2016) (0)
- Jean-Luc Darlix: Renaissance scientist and retrovirologist par excellence (2011) (0)
- Deregulation of microRNAs by HIV-1 Vpr leads to the development of neurocognitive disorders (2011) (0)
- Luc for a Role in Genomic RNA Encapsidation Immunodeficiency Virus Type 1 : Evidence Staufen Is Incorporated in Human The Double-Stranded RNA-Binding Protein (2000) (0)
- PS1-100 Direct induction of the viral restriction factor and negative regulator of the interferon pathway, BST-2/Tetherin, by virus-activated IRF proteins prior to interferon signaling (2011) (0)
- Cheolho Cheong (1974–2016) (2016) (0)
- ILT7 activation and plasmacytoid dendritic cell response are governed by BST2 determinants that are structurally-distinct (2019) (0)
- Protein detect HIV virion on the basis of HIV-1 vpr fusionmolekulen (1995) (0)
- Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain (2017) (0)
- Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome (2021) (0)
- Antagonism of PPARγ for Th17 mucosal immunity restoration and HIV reservoir purging (2019) (0)
- MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4+ T cells (2022) (0)
- HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2 (2014) (0)
- Infection Immediate-Early Protein during HIV-1 ( HIV-1 ) Vpr Functions as an Human Immunodeficiency Virus Type 1 (1998) (0)
- Importin (cid:1) 3 Interacts with HIV-1 Integrase and Contributes to HIV-1 Nuclear Import and Replication (cid:1) (2010) (0)
- Erratum for Essalmani et al., “Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity” (2022) (0)
- Supplemental Information Host MicroRNAs-221 and-222 Inhibit HIV-1 Entry in Macrophages by Targeting the CD 4 Viral Receptor (2017) (0)
- Conserved residues within the HIV-1 Vpu transmembrane-proximal hinge region modulate BST2 binding and antagonism (2017) (0)
- FP07-MO-06 HCV core protein potentiates HIV Vpr neurotoxicity by suppressing autophagy (2009) (0)
- Co-trafficking of HIV-1 VPR and Gag RNA in Oligodendrocytes (1999) (0)
- Human immunodeficiency virus type 1 Vpr‐mediated G2 cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A (0)
- Synthesis of 3,4-Diaryl-3-pyrrolin-2-ones from Pyrrole Weinreb Amides (2012) (0)
- HIV-induced neuroinflammation: impact of PAR1 and PAR2 processing by Furin (2019) (0)
- The spîke (S)-protein of SARS-CoV-2 binds ACE2 and requires proteolytic “priming” at PRRAR685↓ (2021) (0)
This paper list is powered by the following services:
Other Resources About Éric A. Cohen
What Schools Are Affiliated With Éric A. Cohen?
Éric A. Cohen is affiliated with the following schools:
